Interesting update on Sarah Adams – CIA Targeter Responds to FBI Uncovering Secret Biolab with Mystery Vials | SRS #280. Curious how the grades will trend next quarter.
Interesting update on Sarah Adams – CIA Targeter Responds to FBI Uncovering Secret Biolab with Mystery Vials | SRS #280. Curious how the grades will trend next quarter.
Interesting update on Sarah Adams – CIA Targeter Responds to FBI Uncovering Secret Biolab with Mystery Vials | SRS #280. Curious how the grades will trend next quarter.
19 Comments
Interesting update on Sarah Adams – CIA Targeter Responds to FBI Uncovering Secret Biolab with Mystery Vials | SRS #280. Curious how the grades will trend next quarter.
Interesting update on Sarah Adams – CIA Targeter Responds to FBI Uncovering Secret Biolab with Mystery Vials | SRS #280. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Production mix shifting toward Videos might help margins if metals stay firm.
Uranium names keep pushing higher—supply still tight into 2026.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Interesting update on Sarah Adams – CIA Targeter Responds to FBI Uncovering Secret Biolab with Mystery Vials | SRS #280. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.